Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of ...

As part of our Masterclass series, GP specialist in diabetes Dr Elizabeth Martin explains the key points in prevention, diagnosis and management of diabetes in general practice. This series showcases ...

Oracle stock surged Wednesday, as other AI stocks rallied, after President Donald Trump unveiled the Stargate AI infrastructure project with OpenAI and SoftBank. President Trump led a press conference ...